Source: iQoncept / Shutterstock
NeuroOne Medical Tech (NASDAQ:NMTC) just reported results for the fourth quarter of 2023.
- NeuroOne Medical Tech reported earnings per share of -13 cents. This was above the analyst estimate for EPS of -17 cents.
- The company reported revenue of $741,780.
- This was 7.28% worse than the analyst estimate for revenue of $800,000.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2023/12/nmtc-stock-earnings-neuroone-medical-tech-for-q4-of-2023/.
©2023 InvestorPlace Media, LLC